Rocaglamide and silvestrol: a long story from anti-tumor to anti-coronavirus compounds.
Journal
Natural product reports
ISSN: 1460-4752
Titre abrégé: Nat Prod Rep
Pays: England
ID NLM: 8502408
Informations de publication
Date de publication:
01 01 2021
01 01 2021
Historique:
pubmed:
24
7
2020
medline:
13
2
2021
entrez:
24
7
2020
Statut:
ppublish
Résumé
Covering: up to the beginning of 2020Many natural substances have been transformed again and again with regard to their pharmaceutical-medical potential, including new members of a growing class of natural products, the flavaglines. Important representatives are rocaglamide and silvestrol, isolated from the Aglaia species, which are highlighted here. These products started as potential anti-tumor agents five decades ago and have recently proved to be very promising antiviral agents, especially against RNA viruses. Today they are discussed as potential starting compounds for developing drug candidates and therapeutics.
Substances chimiques
Antineoplastic Agents
0
Antiviral Agents
0
Benzofurans
0
Biological Products
0
Triterpenes
0
silvestrol
0
rocaglamide
84573-16-0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM